Anaerobe 2018 Congress Committee Course Director Jeanne Marrazzo, M.D., M.P.H

Total Page:16

File Type:pdf, Size:1020Kb

Anaerobe 2018 Congress Committee Course Director Jeanne Marrazzo, M.D., M.P.H PROGRAM & ABSTRACT BOOK The 14th Biennial Congress of the Anaerobe Society of the Americas Tropicana Hotel Las Vegas, Nevada PROGRAM & ABSTRACT BOOK CONTENTS Course Directors ii Welcome Letter iii About the Society iv Patrons v Exhibitors v Keynote Speaker vi Lifetime Achievement Award vii Accreditation viii Curricular Goals & Objectives viii Presenters & Faculty ix Disclosure Information xii Congress Program xv Abstract Table of Contents 1 Abstracts 3 Poster Index 223 Author Index 233 The 14th Biennial Congress of the Anaerobe Society of the Americas Tropicana Hotel • Las Vegas, Nevada USA ANAEROBE 2018 Congress Committee COURSE DIRECTOR Jeanne Marrazzo, M.D., M.P.H. ASA President University of Alabama Birmingham, AL USA ORGANIZING COMMITTEE Ernesto Abel-Santos, Ph.D. Purnima Kumar, D.D.S. University of Nevada Ohio State University Las Vegas, NV USA Columbus, OH USA David Aronoff, M.D. Elizabeth Nagy, M.D., Ph.D. ASA Past President University of Szeged Vanderbilt University Medical Center Szeged, Hungary Nashville, TN USA Andrew B. Onderdonk, Ph.D Karen Carroll, M.D. Harvard Medical School Johns Hopkins University Boston, MA, USA Baltimore, MD USA Daniel Paredes-Sabja, Ph.D. Diane M. Citron Universidad Andrés Bello Anaerobic Bacteriology Consultant Santiago, Chile Santa Monica, CA USA Cynthia Sears, M.D. Laura M. Cox, Ph.D. ASA Past President Harvard University Johns Hopkins University Boston, MA USA Baltimore, MD USA David Fredricks, M.D. Dennis Stevens, M.D. ASA Vice President University of Washington ASA Past President Seattle, WA USA Veteran Affairs Medical Center Boise, ID USA Dale N. Gerding, M.D. ASA Past President Glenn S. Tillotson, Ph.D. Hines VA Hospital GST Micro LLC Maywood, IL USA Chapel Hill, NC USA Ellie J.C. Goldstein, M.D. Casey M. Theriot, Ph.D. ASA Treasurer, Past President North Carolina State University University of California Raleigh, NC USA Los Angeles, CA USA Vincent Young, M.D., Ph.D. Yiping W. Han, Ph.D. ASA Secretary Columbia University University of Michigan New York, NY USA Ann Arbor, MI USA Sarah Kuehne, Ph.D. Francisco A. Uzal, D.V.M., Ph.D. University of Birmingham University of California Birmingham, United Kingdom Davis, CA USA Ronald J. Goldman, Ph.D. ASA Executive Director Los Angeles, CA USA ANAEROBE SOCIETY OF THE AMERICAS PO Box 452058, Los Angeles, CA 90045 USA Phone: 310-216-9265 Fax: 310-216-9274 Web: www.anaerobe.org E-mail: [email protected] ©2018 Anaerobe Society of the Americas ii Welcome Letter ANAEROBE 2018 Welcome to ANAEROBE 2018, the 14th biennial Congress of the Anaerobe Society of the Americas (ASA)! This forum brings together clinicians and scientists from around the world to engage in presentations, dialogue, and interaction related to the clinical and microbiological aspects of anaerobic bacteriology. The Congress will explore the role of anaerobes in both health and disease, while addressing traditional and emerging technologies for identification and diagnosis. ANAEROBE 2018 again illustrates the international interest in the field of anaerobic bacteriology: 171 abstracts were submitted for presentation, representing the work of over 600 scientists from nearly 30 countries. The Keynote Address will be given by MacArthur Foundation Fellow Sarkis Mazmanian, Ph.D. of the California Institute of Technology. Dr. Mazmanian will discuss the molecular mechanisms of the gut microbiome associated with inflammatory bowel disease. The Lifetime Achievement Award will be presented to Ellen Jo Baron, Ph.D. of Stanford University and Cepheid. Dr. Baron is being recognized for her outstanding career contributions to the fields on anaerobic bacteriology and infectious diseases. We would like to thank the members of the Organizing Committee and the Session Chairs for their assistance in formulating what promises to be another exciting program. We also would like to thank those from industry—both patrons and exhibitors listed on page v—for the financial support that makes this Congress possible, as well as grants from the Burroughs Welcome Fund, Merck, Sanofi-Pasteur, Pfizer, and the European Society of Clinical Microbiology and Infectious Diseases. In addition, we are grateful for our continued relationship with Anaerobe Systems for helping organize the Pre-Congress Workshop, Microbiology Educational Services for providing the continuing education accreditation for laboratory scientists, and to our Anaerobe journal for sponsorship of the Young Investigator’s Competition. Very special thanks goes to Dr. Ronald and Pamela Goldman, who again have done an exemplary job in bringing this meeting together. Finally, please take the opportunity to explore and experience the glitz, glamour, and gaudiness of America’s entertainment capital! Our hope is that ANAEROBE 2018 serves to foster stimulating discussions, as well as cultivate personal relationships that continue to invigorate the entire field beyond the timeframe of this Congress. Jeanne Marrazzo, M.D. ASA President iii ANAEROBE 2018 About the Society ABOUT THE ANAEROBE SOCIETY Founded in 1992, the Anaerobe Society of the Americas, a non-profit foundation, serves as a forum for those interested in anaerobes, anaerobic infections, and related matters. The Society aims: (1) to stimulate interest in anaerobes and to encourage interchange among anaerobists from all disciplines, including medical, dental, veterinary, environmental, and basic sciences; (2) to bring together investigators, clinicians, and laboratory scientists interested in anaerobic infections for formal and informal meetings; (3) to review and assess new advances in the field; (4) to discuss areas of controversy; and (5) to mark future directions. There are four levels of membership: Doctoral, Non-Doctoral, Verified Student, and Retired. Details and application form are available on our web site: www. anaerobe.org. ANAEROBE SOCIETY CONGREssES This is the 14th biennial Anaerobe Society Congress. Past Anaerobe Society sponsored programs were: ANAEROBE 2016 —Nashville, TN USA ANAEROBE 2014 —Chicago, IL USA ANAEROBE 2012 —San Francisco, CA USA ANAEROBE 2010 —Philadelphia, PA USA ANAEROBE 2008 —Long Beach, CA USA ANAEROBE 2006 —Boise, ID USA ANAEROBE 2004 —Annapolis, MD USA ANAEROBE OLYMPIAD 2002 —Park City, UT USA 2001: AN ANAEROBE ODYSSEY —Los Angeles, CA USA ANAEROBE 2000 —Manchester, England ANAEROBE 1998 —Buenas Aires, Argentina ANAEROBE 1996 —Chicago, IL USA ANAEROBE 1994 —Los Angeles, CA USA ANAEROBE 1992 —Los Angeles, CA USA iv Patrons & Exhibitors ANAEROBE 2018 Anaerobe Society of the Americas gratefully acknowledges the following organizations for their generous support of this congress. Support for this activity was received in the form of educational grants from: u Burroughs Wellcome Fund u European Society of Clinical Microbiology and Infectious Diseases Support for this activity from commercial interests include: PLATINUM PATRONS u Merck u Sanofi Pasteur GOLD PATRONS u Pfizer SILVER PATRONS u Acurx Pharmaceuticals u Anaerobe Journal / Elsevier u Cepheid u Rebiotix u Summit Therapeutics BRONZE PATRONS u Anaerobe Systems u TechLab EXHIBITORS u Advanced Instruments u Cayman Chemicals u Clostridium Difficile Foundation u Gut Check Foundation u Key Scientific Products u Microbiology International u Plas-Labs u Seres Therapeutics u Shel Lab v ANAEROBE 2018 Keynote Speaker SARKIS MAZMANIAN, PH.D. Dr. Mazmanian is the Luis B. and Nelly Soux Professor of Microbiology in the Division of Biology & Biological Engineering at the California Institute of Technology and an Investigator of the Heritage Medical Research Institute. He began his college career at the University of California, Los Angeles (UCLA) with the intent of becoming an English major, but after exposure to the microscopic world in the biology lab, he “never looked back.” He earned his Ph.D. at UCLA in 2002— under the tutelage of Dr. Olaf Schneewind— Photo: John D. & Catherine T. MacArthur Foundation Photo: John D. & Catherine T. focusing on the virulence factors related to Staphylococcus aureus. With a Helen Hay Whitney Postdoctoral Fellowship, his interests shifted to gut bacteria, joining the lab of Dr. Dennis Kasper at Harvard University to study Bacteroides fragilis. In 2006, he established his own lab at Cal Tech, where he has taken a broader look at the gut microbiome and potential link to Inflammatory Bowel Disease, Multiple Sclerosis, Parkinson’s disease, and Autism. Immunologic and neurologic imbalances underlie many diseases. The human body represents a scaffold upon which multitudes of commensal species build residence, creating a diverse ecosystem with members of five of the six kingdoms of life. Mechanisms that mediate the interdependent and complex interactions between the microbiome and animals, as well as their influences on human health, represent an exciting frontier of science and medicine. Our laboratory aims to discover how gut bacteria influence the development and function of the immune and nervous systems, with the goal of understanding mechanisms by which the microbiome contributes to the critical balance between health and disease. For his work, Dr. Mazmanian has received numerous honors, including the Burroughs Wellcome Fund’s Investigators in the Pathogenesis of Infectious Disease, (2011), a MacArthur Foundation “genius” grant (2013), and named by Discover Magazine as one of the “Best Brains in Science under 40.” He is a founder of two biotech companies and has or currently serves on the Scientific Advisory Board of over a dozen companies, academic centers, and not- for-profit foundations.
Recommended publications
  • Microbiology Laboratory Exercises Third Edition 2020
    MICROBIOLOGY Laboratory Exercises Third Edition Keddis & Rauschenbach 2020 Photo Credits (in order of contribution): Diane Davis, Ines Rauschenbach & Ramaydalis Keddis Acknowledgements: Many thanks to those in the Department of Biochemistry and Microbiology, Rutgers University, who have through the years inspired our enthusiasm for the science and teaching of microbiology, with special thanks to Diane Davis, Douglas Eveleigh and Max Häggblom. Safety: The experiments included in this manual have been deemed safe by the authors when all necessary safety precautions are met. The authors recommend maintaining biosafety level 2 in the laboratory setting and using risk level 1 organisms for all exercises. License: This work is licensed under a Creative Commons Attribution- NonCommercial-NoDerivatives 4.0 International License Microbiology Laboratory Exercises Third Edition 2020 Ramaydalis Keddis, Ph.D. Ines Rauschenbach, Ph.D. Department of Biochemistry and Microbiology Rutgers, The State University of New Jersey CONTENTS PAGE Introduction Schedule ii Best Laboratory Practices Iii Working in a Microbiology Laboratory iv Exercises Preparation of a Culture Medium 1 Culturing and Handling Microorganisms 3 Isolation of a Pure Culture 5 Counting Bacterial Populations 8 Controlling Microorganisms 10 Disinfectants 10 Antimicrobial Agents: Susceptibility Testing 12 Hand Washing 14 The Lethal Effects of Ultraviolet Light 15 Selection of Fungi from Air 17 Microscopy 21 Morphology and Staining of Bacteria 26 Microbial Metabolism 30 Enzyme Assay 32 Metabolic
    [Show full text]
  • AR-123: 2017 Kentucky Agricultural Experiment Station Annual Report
    University of Kentucky College of Agriculture, Food and Environment AR-130 Agricultural Experiment Station The Kentucky Agricultural Experiment Station 130th Annual Report 2017 Agricultural Kentucky Tobacco Research and Development Center | Veterinary Diagnostic Laboratory | Division of Regulatory Services | Research and Education Center Experiment Station Robinson Forest | Robinson Center for Appalachian Resource Sustainability | University of Kentucky Superfund Research Center | Equine Programs To His Excellency The Honorable Andy Beshear Governor of Kentucky I herewith submit the one hundred and thirtieth annual report of the Kentucky Agricultural Experiment Station for the period ending December 31, 2017. This is done in accordance with an act of Congress, approved March 2, 1887, titled “An act to establish Agricultural Experiment Stations, in connection with the Agricultural Colleges established in the several states under the provisions of an act approved July 2, 1862, and under the acts supplementary thereto,” and also the act of the Kentucky State Legislature, approved February 20, 1888, accepting the provisions of the act of Congress. Very respectfully, Rick Bennett Associate Dean for Research Director, Agricultural Experiment Station Lexington, Kentucky Lexington, Kentucky May 20, 2021 Experiment Station–Affiliated Departments and Centers Agricultural Economics Animal and Food Sciences Biosystems and Agricultural Engineering Community and Leadership Development Dietetics and Human Nutrition Entomology Family Sciences Forestry
    [Show full text]
  • Rapid Identification Ofbacteroides Fragilis with Bile and Antibiotic Disks D
    JOURNAL OF CuNICAL MICROBIOLOGY, Apr. 1977, p. 439-443 Vol. 5, No. 4 Copyright C 1977 American Society for Microbiology Printed in U.S.A. Rapid Identification ofBacteroides fragilis with Bile and Antibiotic Disks D. L. DRAPER1 AND A. L. BARRY* Section ofInfectious and Immunologic Diseases, School of Medicine, University of California, Davis, California 95616, and Clinical Microbiology Laboratories, Medical Center, Sacramento, California 95817* Received for publication 21 December 1976 A simple screening test is described for separating Bacteroides fragilis from other anaerobic gram-negative bacilli. The test utilizes filter paper disks im- pregnated with 25 mg of oxgall (Difco), tested in conjunction with antibiotic identification disks. The bile disks and antibiotic disks are placed on a supple- mented brucella blood agar plate which has been inoculated by swabbing with a standardized cell suspension. After 24 h at 350C in a GasPak jar, resistance to kanamycin and bile is taken as a presumptive identification of B. fragilis. Susceptibility to one or both disks indicates the need for further identification and additional biochemical tests are required. Those strains that produce insuf- ficient growth within 24 h are not likely to be B. fragilis. The reliability of the bile disk method was tested by comparing results with 100 clinical isolates versus results with bile in thioglycolate broth, peptone-yeast extract-glucose broth, and tryptic soy agar. All four bile test methods gave equilvalent results, but the broth media required much longer periods of incubation. Bacteroides fragilis is the anaerobic gram- would quickly identify most B. fragilis strains negative bacillus most frequently recovered could significantly reduce the number of iso- from human infections.
    [Show full text]
  • Effects of Captivity and Artificial Breeding On
    www.nature.com/scientificreports OPEN Effects of captivity and artificial breeding on microbiota in feces of the red-crowned crane (Grus Received: 29 September 2015 Accepted: 26 August 2016 japonensis) Published: 15 September 2016 Yuwei Xie1, Pu Xia1, Hui Wang2, Hongxia Yu1, John P. Giesy1,3,4,5, Yimin Zhang6, Miguel A. Mora7 & Xiaowei Zhang1 Reintroduction of the threatened red-crowned crane has been unsuccessful. Although gut microbiota correlates with host health, there is little information on gut microbiota of cranes under different conservation strategies. The study examined effects of captivity, artificial breeding and life stage on gut microbiota of red-crown cranes. The gut microbiotas of wild, captive adolescent, captive adult, artificially bred adolescent and artificially bred adult cranes were characterized by next-generation sequencing of 16S rRNA gene amplicons. The gut microbiotas were dominated by three phyla: Firmicutes (62.9%), Proteobacteria (29.9%) and Fusobacteria (9.6%). Bacilli dominated the ‘core’ community consisting of 198 operational taxonomic units (OTUs). Both captivity and artificial breeding influenced the structures and diversities microbiota of the gut. Especially, wild cranes had distinct compositions of gut microbiota from captive and artificially bred cranes. The greatest alpha diversity was found in captive cranes, while wild cranes had the least. According to the results of ordination analysis, influences of captivity and artificial breeding were greater than that of life stage. Overall, captivity and artificial breeding influenced the gut microbiota, potentially due to changes in diet, vaccination, antibiotics and living conditions. Metagenomics can serve as a supplementary non-invasive screening tool for disease control. According to the Worldwatch Institute, populations of some avian species are currently declining worldwide, with 1,200 species facing extinction in the next century1.
    [Show full text]
  • Table of Contents I
    Comparison of the gut microbiome of a generalist insect, Spodoptera littoralis and a specialist, leaf and root feeder one, Melolontha hippocastani Dissertation To Fulfill the Requirements for the Degree of „doctor rerum naturalium“ (Dr. rer. nat.) Submitted to the Council of the Faculty Of Biology and Pharmacy of the Friedrich Schiller University By Master of Science of Horticulture Erika Arias Cordero Born on 01.11.1977 in San José, Costa Rica Gutachter: 1. ___________________________ 2. ___________________________ 3. ___________________________ Tag der öffentlichen verteidigung:……………………………………. Table of Contents i Table of Contents 1. General Introduction 1 1.1 Insect-bacteria associations ......................................................................................... 1 1.1.1 Intracellular endosymbiotic associations ........................................................... 2 1.1.2 Exoskeleton-ectosymbiotic associations ........................................................... 4 1.1.3 Gut lining ectosymbiotic symbiosis ................................................................... 4 1.2 Description of the insect species ................................................................................ 12 1.2.1 Biology of Spodoptera littoralis ............................................................................ 12 1.2.2 Biology of Melolontha hippocastani, the forest cockchafer ................................... 14 1.3 Goals of this study ....................................................................................................
    [Show full text]
  • Medical Bacteriology
    LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology.
    [Show full text]
  • AR-128: 2015 Kentucky Agricultural Experiment Station Annual Report
    University of Kentucky College of Agriculture, Food and Environment AR-128 Agricultural Experiment Station The Kentucky Agricultural Experiment Station 128th Annual Report 2015 Agricultural Kentucky Tobacco Research and Development Center | Veterinary Diagnostic Laboratory | Division of Regulatory Services | Research and Education Center Experiment Station Robinson Forest | Robinson Center for Appalachian Resource Sustainability | University of Kentucky Superfund Research Center | Equine Programs To His Excellency The Honorable Matt Bevin Governor of Kentucky I herewith submit the one hundred and twenty-eighth annual report of the Kentucky Agricultural Experiment Station for the period ending December 31, 2015. This is done in accordance with an act of Congress, approved March 2, 1887, titled “An act to establish Agricultural Experiment Stations, in connection with the Agricultural Colleges established in the several states under the provisions of an act approved July 2, 1862, and under the acts supplementary thereto,” and also the act of the Kentucky State Legislature, approved February 20, 1888, accepting the provisions of the act of Congress. Very respectfully, Rick Bennett Associate Dean for Research Director, Agricultural Experiment Station Lexington, Kentucky November 30, 2016 Experiment Station–Affiliated Departments and Centers Agricultural Economics Animal and Food Sciences Biosystems and Agricultural Engineering Community and Leadership Development Dietetics and Human Nutrition Entomology Family Sciences Forestry Horticulture
    [Show full text]
  • ( 12 ) United States Patent
    US009956282B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,956 , 282 B2 Cook et al. (45 ) Date of Patent: May 1 , 2018 ( 54 ) BACTERIAL COMPOSITIONS AND (58 ) Field of Classification Search METHODS OF USE THEREOF FOR None TREATMENT OF IMMUNE SYSTEM See application file for complete search history . DISORDERS ( 56 ) References Cited (71 ) Applicant : Seres Therapeutics , Inc. , Cambridge , U . S . PATENT DOCUMENTS MA (US ) 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al . 3 , 228 , 838 A 1 / 1966 Rinfret (72 ) Inventors : David N . Cook , Brooklyn , NY (US ) ; 3 ,608 ,030 A 11/ 1971 Grant David Arthur Berry , Brookline, MA 4 ,077 , 227 A 3 / 1978 Larson 4 ,205 , 132 A 5 / 1980 Sandine (US ) ; Geoffrey von Maltzahn , Boston , 4 ,655 , 047 A 4 / 1987 Temple MA (US ) ; Matthew R . Henn , 4 ,689 ,226 A 8 / 1987 Nurmi Somerville , MA (US ) ; Han Zhang , 4 ,839 , 281 A 6 / 1989 Gorbach et al. Oakton , VA (US ); Brian Goodman , 5 , 196 , 205 A 3 / 1993 Borody 5 , 425 , 951 A 6 / 1995 Goodrich Boston , MA (US ) 5 ,436 , 002 A 7 / 1995 Payne 5 ,443 , 826 A 8 / 1995 Borody ( 73 ) Assignee : Seres Therapeutics , Inc. , Cambridge , 5 ,599 ,795 A 2 / 1997 McCann 5 . 648 , 206 A 7 / 1997 Goodrich MA (US ) 5 , 951 , 977 A 9 / 1999 Nisbet et al. 5 , 965 , 128 A 10 / 1999 Doyle et al. ( * ) Notice : Subject to any disclaimer , the term of this 6 ,589 , 771 B1 7 /2003 Marshall patent is extended or adjusted under 35 6 , 645 , 530 B1 . 11 /2003 Borody U .
    [Show full text]
  • Obligate Anaerobe in Thioglycollate Medium
    Obligate Anaerobe In Thioglycollate Medium Restiform and pernicious Monty addled her libertarians chastens rurally or alluding drawlingly, is Lorne ungainful? Ernst often laicises intrusively when haustellate Talbert underpeep parchedly and skiagraph her therapies. Adair uncanonizing shily as Mozartean Gifford tellurizing her unsociableness disentwining septically. Anaerobic bacteria can be identified by separate them in test tubes of thioglycollate broth. Aerobic and Anaerobic Growth Lab Exercise 6 Sp16 Canvas. Enriched Thioglycollate Broth is recommended for the isolation cultivation and identification of society wide following of obligate anaerobic bacteria Composition. How to the center of oxygen allowing the pus should not as they may live session is medium in thioglycollate are entire plate in air and aerobic respiration. We extend such an organism an aerotolerant anaerobe and set just off against an additional category of oxygen relationship Those left black the facultative. A movie free from thioglycollate for the growth of aerobic and anaerobic. Opened under a medium onto a medium on medium low, obligate anaerobe in thioglycollate medium, obligate and environmental parameters. Anaerobic Thioglycollate Medium Base Himedia. Find each pipette, obligate anaerobe growth. Incubation obligate anaerobes will grow abnormal in that portion of turkey broth for the. Obligate Anaerobes are actually poisoned by various forms of oxygen. Enriched Thioglycollate Broth M73 VWR. BBL Thioglycollate Medium Enriched with CiteSeerX. The model organism Escherichia coli is a facultative anaerobic bacterium ie it is solar to operate in both aerobic and anaerobic environments. Thioglycollate medium Difco containing 1 dextrose and B. Oxygen Requirements for Microbial Growth Microbiology. Fluid Thioglycollate Medium Flashcards Quizlet. The Thioglycolate medium other the word hand stands out fast its ability to.
    [Show full text]
  • Isolation of Rhizobacteria in Southwestern Québec, Canada: An
    Isolation of rhizobacteria in Southwestern Québec, Canada: An investigation of their impact on the growth and salinity stress alleviation in Arabidopsis thaliana and crop plants Di Fan Department of Plant Science Faculty of Agricultural and Environmental Sciences Macdonald Campus of McGill University 21111 Lakeshore Road, Sainte-Anne-de-Bellevue, Québec H9X 3V9 December 2017 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of DOCTOR OF PHILOSOPHY © Di Fan, Canada, 2017 Table of contents Abstract ................................................................................................. x Résumé ................................................................................................ xiii Acknowledegments ............................................................................. xv Preface ................................................................................................ xviii Contribution of authors ................................................................................ xviii Chapter 1................................................................................................. 1 Introduction ............................................................................................ 1 Chapter 2................................................................................................. 5 Literature Review ................................................................................... 5 2.1 What are root exudates? .........................................................................
    [Show full text]
  • W O 2017/079450 Al 11 May 2017 (11.05.2017) W IPOI PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2017/079450 Al 11 May 2017 (11.05.2017) W IPOI PCT (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K35/741 (2015.01) A61K 35/744 (2015.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 35/745 (2015.01) A61K35/74 (2015.01) DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, C12N1/20 (2006.01) A61K 9/48 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61K 45/06 (2006.01) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (21) International Application Number: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, PCT/US2016/060353 SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (22) International Filing Date: TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, 3 November 2016 (03.11.2016) ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated,for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (30) Priority Data: TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, 62/250,277 3 November 2015 (03.11.2015) US TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (71) Applicants: THE BRIGHAM AND WOMEN'S HOS- LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, PITAL [US/US]; 75 Francis Street, Boston, Massachusetts SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, 02115 (US).
    [Show full text]
  • Official Journal of AFSTAL, ECLAM, ESLAV, FELASA, GV-SOLAS, ILAF, LASA, NVP, SECAL, SGV, SPCAL
    Volume 53 Number 3 June 2019 ISSN 0023-6772 Laboratory Animals THE INTERNATIONAL JOURNAL OF LABORATORY ANIMAL SCIENCE, MEDICINE, TECHNOLOGY AND WELFARE Official Journal of AFSTAL, ECLAM, ESLAV, FELASA, GV-SOLAS, ILAF, LASA, NVP, SECAL, SGV, SPCAL Special Issue: Microbiota Published on behalf of Laboratory Animals Ltd. journals.sagepub.com/home/lan by SAGE Publications Ltd. Does your facility have all the right people with all the right skills? Your animal facilities can get the training, consulting, FDQKHOSƬOOWKHJDSVLQ\RXUSURJUDPPH:KHWKHU\RX DQGVWDƯQJVROXWLRQVWKH\QHHGZLWKInsourcing DUHORRNLQJIRUSHUPDQHQWRUWHPSRUDU\VWDƪZHFDQ SolutionsSM)URPUHJXODWRU\DQG&RQWLQXLQJ3URIHVVLRQDO TXLFNO\SURYLGHTXDOLƬHGSHUVRQQHOLQFOXGLQJEDFNJURXQG 'HYHORSPHQWWUDLQLQJWRSURYLGLQJIXOO\TXDOLƬHGDQLPDO FKHFNV7UDLQLQJDQGIXUWKHUHGXFDWLRQLVDYDLODEOHYLDRXU WHFKQLFLDQVYHWHULQDULDQVDQG3K'OHYHOVFLHQWLVWVZH classroom and eLearning solutions. Visit us at stand A15 at FELASA or at www.criver.com/insourcing Volume 53 Number 3 June 2019 Contents Special Issue: Microbiota Editorial Microbiota, laboratory animals, and research 229 AK Hansen and C Franklin Articles Gnotobiotics: Past, present and future 232 M Basic and A Bleich Humanizing the gut microbiota of mice: Opportunities and challenges 244 R Lundberg The gut microbiota of wild rodents: Challenges and opportunities 252 M Viney The use of non-rodent model species in microbiota studies 259 AC Ericsson The role of gut microbiota in intestinal and liver diseases 271 T Hrncir, L Hrncirova, M Kverka and H Tlaskalova-Hogenova Bacterial
    [Show full text]